TRANSDERMAL NICOTINE FACILITATES SMOKING CESSATION

被引:127
|
作者
ROSE, JE
LEVIN, ED
BEHM, FM
ADIVI, C
SCHUR, C
机构
[1] DUKE UNIV,DEPT PSYCHIAT,DURHAM,NC 27706
[2] UNIV CALIF LOS ANGELES,DEPT PSYCHOL,LOS ANGELES,CA 90024
[3] UNIV CALIF LOS ANGELES,DEPT PSYCHIAT,LOS ANGELES,CA 90024
[4] VET ADM MED CTR BRENTWOOD,NICOTINE RES LAB,LOS ANGELES,CA 90073
关键词
D O I
10.1038/clpt.1990.35
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The efficacy of a transdermal nicotine patch in facilitation of smoking cessation was evaluated in a randomized double-blind trial. Sixty-five smokers who were highly dependent on cigarettes participated in the study, which included a behavioral smoking-cessation program. The rates of continuous abstinence were significantly higher in the nicotine group both initially (55% versus 34%) and at 3 weeks (18% versus 6%). Certain smoking withdrawal symptoms, including negative affect and hypoarousal, were effectively relieved by the nicotine patch. There was a trend toward a reduction in cigarette craving, whereas hunger and habit withdrawal symptoms were not affected. The main side effect associated with the nicotine patch was skin irritation. These findings suggest that a nicotine skin patch may be a useful aid to smoking cessation; however, the combination of other techniques with nicotine replacement may provide a more effective treatment for symptoms such as craving for cigarettes. © 1990.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 50 条
  • [31] A Randomized Trial of Adjunct mHealth Abstinence Reinforcement With Transdermal Nicotine and Counseling for Smoking Cessation
    Alessi, Sheila M.
    Rash, Carla J.
    Petry, Nancy M.
    NICOTINE & TOBACCO RESEARCH, 2017, 19 (03) : 290 - 298
  • [32] The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression
    Thorsteinsson, HS
    Gillin, JC
    Patten, CA
    Golshan, S
    Sutton, LD
    Drummond, S
    Clark, CP
    Kelsoe, J
    Rapaport, M
    NEUROPSYCHOPHARMACOLOGY, 2001, 24 (04) : 350 - 358
  • [33] Effect of 21 mg transdermal nicotine patches and smoking cessation on heart rate variability
    Stein, PK
    Rottman, JN
    Kleiger, RE
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (09): : 701 - 705
  • [34] Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch
    Richmond, RL
    Kehoe, L
    Neto, ACD
    HEART, 1997, 78 (06) : 617 - 618
  • [35] Evaluating the length of transdermal nicotine replacement therapy in relation to the effectiveness of a smoking cessation clinic
    Madison, JS
    Schlede, CM
    Forte, JL
    Covey, DG
    Shaw, RF
    Schlede, CM
    JOURNAL OF ADDICTIVE DISEASES, 1998, 17 (04) : 138 - 138
  • [36] SMOKING-CESSATION TREATMENT COMBINING TRANSDERMAL NICOTINE SUBSTITUTION WITH BEHAVIORAL-THERAPY
    BUCHKREMER, G
    MINNEKER, E
    BLOCK, M
    PHARMACOPSYCHIATRY, 1991, 24 (03) : 96 - 102
  • [37] WEIGHT CHANGE AFTER SMOKING CESSATION USING VARIABLE DOSES OF TRANSDERMAL NICOTINE REPLACEMENT
    DALE, LC
    SCHROEDER, D
    WOLTER, T
    CROGHAN, IT
    HURT, RD
    OFFORD, KP
    JOURNAL OF ADDICTIVE DISEASES, 1995, 14 (03) : A7 - A7
  • [38] The Effects of Transdermal Nicotine Therapy for Smoking Cessation on Depressive Symptoms in Patients with Major Depression
    Haraldur S Thorsteinsson
    J Christian Gillin
    Christi A Patten
    Shahrokh Golshan
    Laura D Sutton
    Sean Drummond
    Camellia P Clark
    John Kelsoe
    Mark Rapaport
    Neuropsychopharmacology, 2001, 24 : 350 - 358
  • [39] Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling
    Fiscella, K
    Franks, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (16): : 1247 - 1251
  • [40] Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation
    Davidson, M
    Epstein, M
    Burt, R
    Schaefer, C
    Whitworth, G
    McDonald, A
    ARCHIVES OF FAMILY MEDICINE, 1998, 7 (06) : 569 - 574